N,N-bis(furan-2-ylmethyl)-1-[5-(1-methyl-3-naphthalen-2-ylpyrazol-5-yl)-1-azabicyclo[2.2.2]octan-2-yl]methanamine

C32H34N4O2 — CID 75061316

IUPACN,N-bis(furan-2-ylmethyl)-1-[5-(1-methyl-3-naphthalen-2-ylpyrazol-5-yl)-1-azabicyclo[2.2.2]octan-2-yl]methanamine
SMILESCn1nc(-c2ccc3ccccc3c2)cc1C1CN2CCC1CC2CN(Cc1ccco1)Cc1ccco1
InChIInChI=1S/C32H34N4O2/c1-34-32(18-31(33-34)26-11-10-23-6-2-3-7-24(23)16-26)30-22-36-13-12-25(30)17-27(36)19-35(20-28-8-4-14-37-28)21-29-9-5-15-38-29/h2-11,14-16,18,25,27,30H,12-13,17,19-22H2,1H3
InChIKeyPOYOECKUCHPQML-UHFFFAOYSA-N
MW506.65 g/mol
LogP6.31
Rot. Bonds8

About N,N-bis(furan-2-ylmethyl)-1-[5-(1-methyl-3-naphthalen-2-ylpyrazol-5-yl)-1-azabicyclo[2.2.2]octan-2-yl]methanamine

N,N-bis(furan-2-ylmethyl)-1-[5-(1-methyl-3-naphthalen-2-ylpyrazol-5-yl)-1-azabicyclo[2.2.2]octan-2-yl]methanamine (PubChem CID 75061316) has the molecular formula C32H34N4O2 and a molecular weight of 506.65 g/mol. Its IUPAC name is N,N-bis(furan-2-ylmethyl)-1-[5-(1-methyl-3-naphthalen-2-ylpyrazol-5-yl)-1-azabicyclo[2.2.2]octan-2-yl]methanamine.

Molecular Properties

Compound NameN,N-bis(furan-2-ylmethyl)-1-[5-(1-methyl-3-naphthalen-2-ylpyrazol-5-yl)-1-azabicyclo[2.2.2]octan-2-yl]methanamine
PubChem CID75061316
Molecular FormulaC32H34N4O2
Molecular Weight506.65 g/mol
Exact Mass506.27
IUPAC NameN,N-bis(furan-2-ylmethyl)-1-[5-(1-methyl-3-naphthalen-2-ylpyrazol-5-yl)-1-azabicyclo[2.2.2]octan-2-yl]methanamine
SMILESCn1nc(-c2ccc3ccccc3c2)cc1C1CN2CCC1CC2CN(Cc1ccco1)Cc1ccco1
InChIInChI=1S/C32H34N4O2/c1-34-32(18-31(33-34)26-11-10-23-6-2-3-7-24(23)16-26)30-22-36-13-12-25(30)17-27(36)19-35(20-28-8-4-14-37-28)21-29-9-5-15-38-29/h2-11,14-16,18,25,27,30H,12-13,17,19-22H2,1H3
InChIKeyPOYOECKUCHPQML-UHFFFAOYSA-N
XLogP6.31
TPSA50.58 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds8
Heavy Atoms38
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500506.65
LogP ≤ 56.31
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Analyze N,N-bis(furan-2-ylmethyl)-1-[5-(1-methyl-3-naphthalen-2-ylpyrazol-5-yl)-1-azabicyclo[2.2.2]octan-2-yl]methanamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N,N-bis(furan-2-ylmethyl)-1-[5-(1-methyl-3-naphthalen-2-ylpyrazol-5-yl)-1-azabicyclo[2.2.2]octan-2-yl]methanamine?
The IUPAC name of N,N-bis(furan-2-ylmethyl)-1-[5-(1-methyl-3-naphthalen-2-ylpyrazol-5-yl)-1-azabicyclo[2.2.2]octan-2-yl]methanamine (CID 75061316) is N,N-bis(furan-2-ylmethyl)-1-[5-(1-methyl-3-naphthalen-2-ylpyrazol-5-yl)-1-azabicyclo[2.2.2]octan-2-yl]methanamine.
What is the SMILES notation for N,N-bis(furan-2-ylmethyl)-1-[5-(1-methyl-3-naphthalen-2-ylpyrazol-5-yl)-1-azabicyclo[2.2.2]octan-2-yl]methanamine?
The canonical SMILES for N,N-bis(furan-2-ylmethyl)-1-[5-(1-methyl-3-naphthalen-2-ylpyrazol-5-yl)-1-azabicyclo[2.2.2]octan-2-yl]methanamine is Cn1nc(-c2ccc3ccccc3c2)cc1C1CN2CCC1CC2CN(Cc1ccco1)Cc1ccco1.
What is the InChIKey of N,N-bis(furan-2-ylmethyl)-1-[5-(1-methyl-3-naphthalen-2-ylpyrazol-5-yl)-1-azabicyclo[2.2.2]octan-2-yl]methanamine?
The InChIKey is POYOECKUCHPQML-UHFFFAOYSA-N. The full InChI is InChI=1S/C32H34N4O2/c1-34-32(18-31(33-34)26-11-10-23-6-2-3-7-24(23)16-26)30-22-36-13-12-25(30)17-27(36)19-35(20-28-8-4-14-37-28)21-29-9-5-15-38-29/h2-11,14-16,18,25,27,30H,12-13,17,19-22H2,1H3.
What are the key properties of N,N-bis(furan-2-ylmethyl)-1-[5-(1-methyl-3-naphthalen-2-ylpyrazol-5-yl)-1-azabicyclo[2.2.2]octan-2-yl]methanamine?
N,N-bis(furan-2-ylmethyl)-1-[5-(1-methyl-3-naphthalen-2-ylpyrazol-5-yl)-1-azabicyclo[2.2.2]octan-2-yl]methanamine has a molecular weight of 506.65 g/mol, XLogP of 6.31, 8 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N,N-bis(furan-2-ylmethyl)-1-[5-(1-methyl-3-naphthalen-2-ylpyrazol-5-yl)-1-azabicyclo[2.2.2]octan-2-yl]methanamine is sourced from PubChem (CID 75061316), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).